Article
Liver transplant recipient sera derived soluble HLA mediates allele specific CTL apoptosis.
Transplantation - 15 Jan 2000
Smith M A, Naziruddin B, Poindexter N J, Haynes A E, Howard T, Mohanakumar T
Abstract excerpt
BACKGROUND: Significant levels of donor soluble human leukocyte antigen (HLA) class I (sHLA) are present in patients after transplants. We investigated the possibility that sHLA may inhibit cytolytic T lymphocyte (CTL) activity by inducing apoptosis of the CTL, thereby serving as a mechanism for specific tolerance. METHODS: sHLA-A2 and A3 were isolated from the sera of liver transplant recipients by affinity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
